Market Cap : 501.55 M | Enterprise Value : 501.55 M | PE Ratio : 4.07 | PB Ratio : 1.05 |
---|
NYSE:HQL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:HQL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.
Tekla Life Sciences Investors's Net Change in Cash for the six months ended in Sep. 2020 was $0.0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2020 was $0.0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Tekla Life Sciences Investors's Net Change in Cash for the fiscal year that ended in Sep. 2020 is calculated as
Net Change in Cash | = | Cash Flow from Operations | + | Cash Flow from Investing | + | Cash Flow from Financing | + | Effect of Exchange Rate Changes |
= | 0 | + | 0 | + | 0 | + | 0 | |
= | 0.0 |
Tekla Life Sciences Investors's Net Change in Cash for the quarter that ended in Sep. 2020
For stock reported semi-annually, GuruFocus uses latest annual data as the TTM data. Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2020 was $0.0 Mil. * All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes
= 0 + 0 + 0 + 0
= 0.0
No Headline